These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 25530051)

  • 21. Potential cardiovascular risk factors in chronic kidney disease: AGEs, total homocysteine and metabolites, and the C-reactive protein.
    Busch M; Franke S; Müller A; Wolf M; Gerth J; Ott U; Niwa T; Stein G
    Kidney Int; 2004 Jul; 66(1):338-47. PubMed ID: 15200442
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Homocysteine, folate, hs-C-reactive protein, tumor necrosis factor alpha and inflammatory proteins: are these biomarkers related to nutritional status and cardiovascular risk in childhood-onset systemic lupus erythematosus?
    Salomão RG; de Carvalho LM; Izumi C; Czernisz ÉS; Rosa JC; Antonini SRR; Bueno AC; Almada MORDV; Coelho-Landell CA; Jordão AA; Ferriani VPL; Monteiro JP
    Pediatr Rheumatol Online J; 2018 Jan; 16(1):4. PubMed ID: 29316941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pentoxifylline decreases serum levels of tumor necrosis factor alpha, interleukin 6 and C-reactive protein in hemodialysis patients: results of a randomized double-blind, controlled clinical trial.
    González-Espinoza L; Rojas-Campos E; Medina-Pérez M; Peña-Quintero P; Gómez-Navarro B; Cueto-Manzano AM
    Nephrol Dial Transplant; 2012 May; 27(5):2023-8. PubMed ID: 21968012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The kynurenines are associated with oxidative stress, inflammation and the prevalence of cardiovascular disease in patients with end-stage renal disease.
    Pawlak K; Domaniewski T; Mysliwiec M; Pawlak D
    Atherosclerosis; 2009 May; 204(1):309-14. PubMed ID: 18823890
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accumulation of retained nonfunctional arteriovenous grafts correlates with severity of inflammation in asymptomatic ESRD patients.
    Wasse H; Cardarelli F; De Staercke C; Hooper WC; Long Q
    Nephrol Dial Transplant; 2013 Apr; 28(4):991-7. PubMed ID: 23090982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association between white blood cell count and levels of serum homocysteine in end-stage renal failure patients treating with hemodialysis.
    Bradran A; Nasri H
    J Ayub Med Coll Abbottabad; 2006; 18(1):22-6. PubMed ID: 16773964
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-18 is involved in vascular injury in end-stage renal disease patients.
    Porazko T; Kúzniar J; Kusztal M; Kúzniar TJ; Weyde W; Kuriata-Kordek M; Klinger M
    Nephrol Dial Transplant; 2009 Feb; 24(2):589-96. PubMed ID: 18775894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relations of inflammatory markers to lipid levels and autonomic tone in patients with moderate and severe chronic kidney disease and in patients under maintenance hemodialysis.
    Psychari SN; Sinos L; Iatrou C; Liakos G; Apostolou TS
    Clin Nephrol; 2005 Dec; 64(6):419-27. PubMed ID: 16370154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship between the soluble F11 receptor and markers of inflammation in hemodialysis patients.
    Salifu MO; Kolff Q; Murty P; Haria DM; Zimpa M; Shakeel M; Lee H; Kornecki E; Babinska A
    J Investig Med; 2007 Apr; 55(3):115-9. PubMed ID: 17481380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Apelin: a potential link between inflammation and cardiovascular disease in end stage renal disease patients.
    El-Shehaby AM; El-Khatib MM; Battah AA; Roshdy AR
    Scand J Clin Lab Invest; 2010 Oct; 70(6):421-7. PubMed ID: 20645679
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protein oxidative stress and dyslipidemia in dialysis patients.
    Marques de Mattos A; Marino LV; Ovidio PP; Jordão AA; Almeida CC; Chiarello PG
    Ther Apher Dial; 2012 Feb; 16(1):68-74. PubMed ID: 22248198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hyperhomocysteinemia and end-stage renal disease: determinants and association with cardiovascular disease in Tunisian patients.
    Fellah H; Feki M; Hsairi M; Sanhaji H; Kaabachi N; Ben Abdallah T; Massy ZA; Ben Maiz H; Lacour B; Mebazaa A
    Clin Chem Lab Med; 2003 May; 41(5):675-80. PubMed ID: 12812266
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antioxidant therapy does not ameliorate oxidative stress and inflammation in patients with end-stage renal disease.
    Kamgar M; Zaldivar F; Vaziri ND; Pahl MV
    J Natl Med Assoc; 2009 Apr; 101(4):336-44. PubMed ID: 19397224
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Homocysteine and methionine metabolism in ESRD: A stable isotope study.
    van Guldener C; Kulik W; Berger R; Dijkstra DA; Jakobs C; Reijngoud DJ; Donker AJ; Stehouwer CD; De Meer K
    Kidney Int; 1999 Sep; 56(3):1064-71. PubMed ID: 10469375
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dialysis modality and nutritional status are associated with variability of inflammatory markers.
    Snaedal S; Qureshi AR; Lund SH; Germanis G; Hylander B; Heimbürger O; Carrero JJ; Stenvinkel P; Bárány P
    Nephrol Dial Transplant; 2016 Aug; 31(8):1320-7. PubMed ID: 27220753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Elevated homocysteine levels in patients with end-stage renal disease.
    Nair AP; Nemirovsky D; Kim M; Geer EB; Farkouh ME; Winston J; Halperin JL; Robbins MJ
    Mt Sinai J Med; 2005 Nov; 72(6):365-73. PubMed ID: 16358160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of chronic kidney disease and type of dialysis on serum levels of adiponectin, TNF-alpha and high sensitive C-reactive protein.
    Kir HM; Eraldemir C; Dervisoglu E; Caglayan C; Kalender B
    Clin Lab; 2012; 58(5-6):495-500. PubMed ID: 22783580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of hepatitis C virus on C-reactive protein and interleukin-6 in hemodialysis patients.
    Afzal N; Abbas S; Ahmed A; Arif M; Javeed K
    Iran J Kidney Dis; 2011 Jul; 5(3):182-6. PubMed ID: 21525578
    [TBL] [Abstract][Full Text] [Related]  

  • 39. How does short-term low-dose simvastatin influence serum prohepcidin levels in patients with end-stage renal disease? A pilot study.
    Li XY; Chang JP; Su ZW; Li JH; Peng BS; Zhu SL; Cai AJ; Zhang J; Jiang Y
    Ther Apher Dial; 2010 Jun; 14(3):308-14. PubMed ID: 20609184
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma cytokine levels predict mortality in patients with acute renal failure.
    Simmons EM; Himmelfarb J; Sezer MT; Chertow GM; Mehta RL; Paganini EP; Soroko S; Freedman S; Becker K; Spratt D; Shyr Y; Ikizler TA;
    Kidney Int; 2004 Apr; 65(4):1357-65. PubMed ID: 15086475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.